PMID- 9540200
OWN - NLM
STAT- MEDLINE
DCOM- 19980424
LR  - 20190516
IS  - 0108-2701 (Print)
IS  - 0108-2701 (Linking)
VI  - 54 ( Pt 2)
DP  - 1998 Feb 15
TI  - Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA).
PG  - 229-31
AB  - The crystal structure of 3,4-methylenedioxymethamphetamine [systematic name: 
      N-methyl-1-[3,4-(methylenedioxy) phenyl]-2-aminopropane] hydrochloride, 
      C11H15NO2.HCl, also known as 'ecstasy' or MDMA, has been determined by X-ray 
      diffraction.
FAU - Morimoto, B H
AU  - Morimoto BH
AD  - AMUR Pharmaceuticals, San Carlos, CA 94070, USA. morimoto@amur.com
FAU - Lovell, S
AU  - Lovell S
FAU - Kahr, B
AU  - Kahr B
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Acta Crystallogr C
JT  - Acta crystallographica. Section C, Crystal structure communications
JID - 8305826
RN  - 0 (Hallucinogens)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Crystallization
MH  - Crystallography, X-Ray
MH  - Hallucinogens/*chemistry
MH  - Hydrogen Bonding
MH  - Models, Molecular
MH  - Molecular Structure
MH  - N-Methyl-3,4-methylenedioxyamphetamine/*chemistry
EDAT- 1998/04/16 00:00
MHDA- 1998/04/16 00:01
CRDT- 1998/04/16 00:00
PHST- 1998/04/16 00:00 [pubmed]
PHST- 1998/04/16 00:01 [medline]
PHST- 1998/04/16 00:00 [entrez]
AID - 10.1107/s0108270197012390 [doi]
PST - ppublish
SO  - Acta Crystallogr C. 1998 Feb 15;54 ( Pt 2):229-31. doi: 
      10.1107/s0108270197012390.